A novel peripheral 5HT2A antagonist for treating metabolic liver diseases (IMAGE)

GIST (Gwangju Institute of Science and Technology)

A novel peripheral 5HT2A antagonist for treating metabolic liver diseases

Caption

Researchers discovered a compound 11c, a peripheral 5HT2A antagonist, exhibits promising efficacy against metabolic dysfunction-associated steatohepatitis (MASH) and associated liver diseases, offering hope for improved treatment outcomes.

Credit

Jin Hee Ahn from GIST, Korea.

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.